序号 |
标题 |
次数 |
作者 |
发布时间 |
73666 |
Amino-PEG8-Boc CAS:756526-06-4 |
100 |
h |
2024-12-24 |
73667 |
DOTAP:Chol:PEG2000-ATP Liposome (PEGylated),DOTAP:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
91 |
axc |
2024-12-24 |
73668 |
Ga-DOTA-FAPI/ANCP-PSMA,大环化合物 |
114 |
kx |
2024-12-24 |
73669 |
5,10,15,20-四(4-甲氧羰基苯基)卟啉(TCMPP) |
115 |
WYQ |
2024-12-24 |
73670 |
N3-PEG4-C2-Pfp ester CAS:1353012-00-6 |
82 |
h |
2024-12-24 |
73671 |
mPEG40-OH cas:1346556-95-3 甲氧基四十聚乙二醇-羟基 |
94 |
zyl |
2024-12-24 |
73672 |
PC:Chol:PEG2000-ATP Liposome (PEGylated),PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
127 |
axc |
2024-12-24 |
73673 |
perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate ,PDB-PFP,2088570-81-2,ADC试剂 |
83 |
hyy |
2024-12-24 |
73674 |
Ald-Ph-amido-PEG3-C1-Boc CAS:1007215-94-2 |
71 |
h |
2024-12-24 |
73675 |
2 5 8 11-Tetraoxaheptadecane-17-thiol cas:205490-80-8 |
120 |
zyl |
2024-12-24 |
73676 |
72573-82-1,Gd-DOTA,钆特酸,大环化合物 |
101 |
kx |
2024-12-24 |
73677 |
PS:PC:Chol:PEG2000-ATP Liposome (PEGylated),PS:PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
158 |
axc |
2024-12-24 |
73678 |
mPEG45-SSG的结构式 |
98 |
zyl |
2024-12-24 |
73679 |
DOTA satoreotide,大环化合物 |
84 |
kx |
2024-12-24 |
73680 |
PS:PC:Chol:PEG2000-ATP Liposome (PEGylated),PS:PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
157 |
axc |
2024-12-24 |
73681 |
mPEG62-OH 甲氧基六二聚乙二醇-羟基 |
124 |
zyl |
2024-12-24 |
73682 |
DOTA-甲基四嗪,1610950-41-8,DOTA-多肽分子探针 |
82 |
kx |
2024-12-24 |
73683 |
mPEG45-OH 甲氧基四十五聚乙二醇-羟基 |
110 |
zyl |
2024-12-24 |
73684 |
DOPG:DOPC:Chol:PEG2000-ATP Liposome (PEGylated),DOPG:DOPC:胆固醇:聚乙二醇2000-ATP脂质体(聚乙二醇化) |
189 |
axc |
2024-12-24 |
73685 |
2,5-Dioxo-1-(4-(pyridin-2-yldisulfanyl)butanoyloxy)pyrrolidine-3-sulfonic acid,SPDB-sulfo,1628113-16-5,抗体- 药物偶联物 |
70 |
hyy |
2024-12-24 |
73686 |
5-(4-羧基苯基)-10,15,20-四苯基镁卟啉(MgTPPCOOH) |
93 |
WYQ |
2024-12-24 |
73687 |
mPEG1-OCH2CH2COONHS Ester cas:1127247-34-0 |
94 |
zyl |
2024-12-24 |
73688 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪,大环化合物 |
101 |
kx |
2024-12-24 |
73689 |
橙红色固体5,15-二(4-乙炔基苯基)-10,20-二苯基钴卟啉(CoDETPP) |
112 |
WYQ |
2024-12-24 |
73690 |
原卟啉二甲酯钴配合物PPDMECo |
83 |
WYQ |
2024-12-24 |
73691 |
DOPG:胆固醇:聚乙二醇2000-ATP脂质体(聚乙二醇化),DOPG:Chol:PEG2000-ATP Liposome (PEGylated) |
144 |
axc |
2024-12-24 |
73692 |
mPEG15-OCH2CH2COOH的介绍 |
92 |
zyl |
2024-12-24 |
73693 |
127985-74-4,(p-SCN-Bn)-dota,2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸,大环化合物 |
83 |
kx |
2024-12-24 |
73694 |
N-Succinimidyl 4-(2-pyridyldithio)butanoate,SPDB,115088-06-7,ADC试剂 |
98 |
hyy |
2024-12-24 |
73695 |
对照阿仑膦酸盐脂质体(阴离子),Control Alendronate Liposome (Anionic) |
134 |
axc |
2024-12-24 |
73696 |
mPEG44-OCH2COOH的介绍 |
103 |
zyl |
2024-12-24 |
73697 |
5-对-(对羰基苯甲酸)-氨基苯基-10,15,20-三苯基卟啉锌(Ⅱ)Zn(p-CPTPP) |
113 |
WYQ |
2024-12-24 |
73698 |
1189194-65-7,DOTA-CH2-Alkynyl (TFA salt),大环化合物 |
80 |
kx |
2024-12-24 |
73699 |
Alendronate Liposome (Anionic) 阿仑膦酸盐脂质体(阴离子) |
123 |
axc |
2024-12-24 |
73700 |
meso-四(4-甲基-3-磺酸苯基)卟啉[简称T(4-MP)PS4] |
136 |
WYQ |
2024-12-24 |
73701 |
mPEG9-OCH2COOH的结构式 |
106 |
zyl |
2024-12-24 |
73702 |
SPDMB,2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,2101206-29-3,抗体- 药物偶联物 |
121 |
hyy |
2024-12-24 |
73703 |
PAMAM-DOTA-Gd,大环化合物 |
72 |
kx |
2024-12-24 |
73704 |
四(4-溴苯基)卟啉银(AgTBrPP),AgTBrPP是一种含银的金属卟啉配合物。 |
135 |
WYQ |
2024-12-24 |
73705 |
mPEG36-NH-Mal 甲氧基三十六聚乙二醇-NH-马来酰亚胺 |
146 |
zyl |
2024-12-24 |
73706 |
DOTA-TATE,177943-88-3,大环化合物 |
110 |
kx |
2024-12-24 |
73707 |
meso-四(3-氯苯基)卟啉(T(3-C1P)P) |
95 |
WYQ |
2024-12-24 |
73708 |
mPEG48-OCH2CH2COOH cas:125220-94-2 |
134 |
zyl |
2024-12-24 |
73709 |
对照阿仑膦酸盐脂质体(中性),Control Alendronate Liposome (Neutral) |
90 |
axc |
2024-12-24 |
73710 |
甲基丙烯酸十二烷氧基四苯基卟啉(MM-TPP-12C) |
95 |
WYQ |
2024-12-24 |